FDA Approves GSK’s 5-in-1 Meningococcal Vaccine
On Feb. 14, 2025, British pharmaceutical and biotechnology company GSK plc announced that the U.S. Food and Drug Administration (FDA) approved its 5-in-1 meningococcal vaccine PENMENVY for licensure and use in individuals aged 10 through 25 years. The vaccine targets five major serogroups of the bacterium Neisseria meningitidis (A, B, C, W, and Y), which […]
Young Girl Denied Heart Transplant Over Refusal to Get COVID and Flu Shots
The mother of a 12-year-old girl said an Ohio children’s hospital denied her daughter a spot on an organ transplant list due to her vaccination status, specifically the COVID-19 and flu shots. The mother, Jeneen Deal, who is related to Vice President J.D. Vance’s half-siblings through marriage, adopted Adeline from China when she was just […]
Measles Outbreak in Texas
There has been a lot of media attention given lately to the measles outbreak in Texas. The outbreak now accounts for 90 cases—77 of them involving children under the age of 18. It has been reported that “most of those infected” either have not be vaccinated for measles or have an “unknown vaccination status,” while […]
Gardasil Lawsuit Worth $8 Billion Set for Jury Trial
Merck & Co. is about to face a jury trial defending against a claim that Merck advertisements misrepresented that the Gardasil vaccine was safe and effective. The jury will determine whether the drug giant hid the risks and side effects associated with its lucrative HPV (human papilloma virus) vaccine marketed to children and young adults.1 […]
Argentina Will Follow U.S. and Exit the World Health Organization
On Feb. 5, 2025, Argentina announced that it would leave the World Health Organization (WHO), following the example of the United States after President Donald Trump announced in an Executive Order (EO) on Jan. 20, 2025 that the US would exit and stop supporting the global health agency.1 Similar to the reasons that Trump cited […]
BARDA’s Big Bird Flu Vax Contract With Moderna
Last month, Moderna, Inc. slashed its revenue forecast for this year by $1 billion, prompting its stock price to plunge by more than 20 percent to $33.44. In September 2024, Moderna estimated its revenue for 2025 would be $2.5 billion to $3.5 billion, but the company revised its forecast on Jan. 13, 2025 to $1.5 […]